✨ Your Portfolio is fetched and updated from zerodha.

Pharma Sector

Index
  • 1m
  • 6m
  • ytd
  • 1y
  • 3y
  • 5y
  • max
Constituents (240 Companies)
Company Name
PE
Market Cap (Cr.)
M.Cap (Cr.)
38.87
4,06,147
71.11
1,76,708
22.33
1,21,525
56.61
1,21,147
17.43
1,00,596
19.30
94,968
53.36
93,420
20.82
90,051
29.70
67,845
19.06
65,221
40.56
61,200
77.55
53,038
67.96
51,221
132
50,825
45.94
43,885
86.74
39,144
43.07
33,533
32.41
31,555
38.79
30,657
105
27,067
38.89
26,647
-
26,452
34.67
25,803
28.69
23,204
95.21
22,865
113
22,697
-
21,756
55.94
21,653
-
20,333
53.66
19,190
64.17
18,380
28.56
18,116
37.44
17,883
139
15,973
24.94
14,683
41.12
14,643
64.62
14,474
8.47
14,386
28.08
13,464
28.18
12,563
21.14
11,214
53.48
10,696
25.86
10,688
29.51
10,399
76.89
10,331
31.57
9,685
48.37
9,436
21.97
8,728
23.65
8,282
29.40
7,832
64.67
7,186
20.95
7,153
30.76
6,935
35.64
6,348
181
5,393
110
4,906
-
4,719
22.52
4,483
35.30
4,393
-
4,312
50.00
4,261
18.39
3,962
28.67
3,911
43.47
3,787
25.37
3,473
54.27
3,357
24.78
3,243
45.32
2,869
424
2,722
36.98
2,705
25.33
2,660
27.83
2,577
8.09
2,561
221
2,538
-
2,404
37.53
2,046
27.17
1,829
177
1,794
54.00
1,716
39.75
1,686
24.77
1,641
26.24
1,511
23.28
1,442
27.31
1,398
36.16
1,359
12.35
1,354
59.84
1,200
-
1,067
12.19
1,053
43.65
911
20.54
892
22.26
862
20.03
861
42.26
835
-
824
3.55
821
7.85
820
21.85
763
35.96
738
37.11
732
43.15
689
20.41
675
23.75
665
30.76
628
32.41
612
11.17
600
57.93
550
15.92
525
77.70
489
-
479
45.52
478
-
456
33.41
447
53.70
444
40.12
415
64.17
398
45.34
365
20.66
357
30.15
354
20.61
346
36.84
346
44.59
335
-
329
49.19
327
33.06
317
-
314
101
312
30.62
301
69.14
284
66.54
276
10.82
263
27.45
262
128
256
31.48
256
19.35
248
-
238
-
206
13.84
186
9.71
174
6.56
172
660
171
-
168
31.41
168
49.63
167
15.71
151
-
148
13.60
147
42.86
145
10.63
144
17.76
143
31.10
137
35.90
132
18.22
130
10.57
128
319
127
14.80
125
163
114
29.06
109
15.12
108
28.30
107
-
101
15.28
101
32.20
100
42.51
99
9.06
97
29.68
92
18.96
91
-
88
17.57
85
13.97
80
673
74
8.76
74
-
74
14.69
73
165
71
15.29
66
9.36
64
22.88
64
14.69
62
16.29
62
8.60
62
-
60
3.77
57
-
57
-
46
10.71
45
-
42
27.20
42
12.45
42
95.31
42
-
42
17.78
41
36.51
40
38.84
40
19.22
39
38.18
37
-
37
69.92
36
157
35
8.70
35
9.95
34
-
34
8.02
33
12.79
33
-
33
58.70
32
35.19
30
51.41
30
161
29
12.79
26
-
23
74.57
22
-
21
-
21
20.61
21
26.81
19
73.92
19
-
17
16.77
17
-
17
38.71
15
-
14
-
12
53.11
12
107
11
-
10
22.64
10
-
10
-
9
110
9
-
9
869
8
-
8
340
7
79.18
5
-
5
-
5
-
4
39.42
3
-
2
Showing 5 240 of 240 Show More
Market Share

    Select a Metric
    • Fermentation Based API Products - Market Share (%)
    • Gastrointestinal (Nurokind-LC) - Market Share (%)
    • Depression (Placida) - Market Share (%)
    • Anti-Hypertensives (Amolkind-AT) Market Share (%)
    • Anti Fungal Antibiotics (Terbinaforce) - Market Share (%)
    • Birth Control (Unwanted-72) - Market Share (%)
    • Anti - Diabetes - Market Share (%)
    • Anti-Infectives - Market Share (%)
    • Cardiovascular - Market Share (%)
    • Gastro-Intestinal - Market Share (%)
    • Pharmaceutical Sector - Market Share (%)
    • Sex Stimulants - Market Share (%)
    • Vaccines - Market Share (%)
    • Vitamin & Dietary Supplements - Market Share (%)
    Operational Metrics

    Select a Metric
    • Pharma spend as a % of GDP - India (%)
    • Pharma spend as a % of GDP - Korea (%)
    • Pharma spend as a % of GDP - USA (%)
    • Domestic Pharma - Monthly Sales (Crs)
    • Domestic Pharma Price Growth (%)
    • Domestic Pharma Volume Growth (%)
    • Total ANDA's Approved by USFDA

      Select a Metric
      • Fermentation Capacity (KL)
      • No Of Pharmacies (.)
      • Number of ANDA's Approved By USFDA (.)
      • Number of ANDA's Filed in USA (.)
      • Manufacturing Capacity - Metformin (MTPA)
      • No of Pharmacy Outlets - Kolkata (.)
      • Quarterly Sales Volume - Injectables (Nos)
      • Quarterly Sales Volume - Nutraceuticals (Nos)
      • Quarterly Sales Volume - Orals (Nos)
      • Realization / Tonne - Piperazine (Rs/MT)
      • Manufacturing Capacity - Pyridin-3-One (MTPA)
      • Realization / Tonne - Pyridin-3-One (Rs/MT)
      • Domestic Sales Growth - YoY (%)
      • Number of ANDA's Approved (.)
      • Number of ANDA's Filed in Europe
      • Number of ANDA's Approved in Europe
      • Canada DMF fillings (.)
      • US DMF Filings (.)
      • Australia DMF fillings (.)
      • US DMF Approval (.)
      • Europe DMF Filings (.)
      • DMF Filingsby API (.)
      • Total reactor capacity (kL)
      • Global DMFs filed (.)
      • APIs Production Capacity (MTPA)
      • Japan DMF Filings (.)
      • Realization - Tetralone (Rs/Tonne)
      • Manufacturing Capacity - Omeprazole (MTPA)
      • Capacity Utilization - Esomeprazole (%)
      • Realization - Pantaprazole Sodium (Rs/Tonne)
      • Capacity Utilization - Benzimidazole (%)
      • Capacity Utilization - Omeprazole (%)
      • Manufacturing Capacity - Benzimidazole (MTPA)
      • Realization - Chloro Compound (Rs/Tonne)
      • Manufacturing Capacity - Pantaprazole (MTPA)
      • Realization - Op. Sulphide (Rs/Tonne)
      • Realization - Esomeprazole Magnesium (Rs/Tonne)
      • Capacity Utilization - Chloro Compound (%)
      • Capacity Utilization - Pantaprazole (%)
      • Realization - Benzimidazole (Rs/Tonne)
      • Realization - Omeprazole Powder (Rs/Tonne)
      • Manufacturing Capacity - Esomeprazole (MTPA)
      • Manufacturing Capacity - Chloro Compound (MTPA)
      • Realization - Ammonium Sulphate (Rs/Tonne)
      • Manufacturing Capacity - Ibuprofen (MTPA)
      • Capacity Utilization - Pharmaceuticals (%)
      • Number of ANDA's Filed in Canada
      • Number of ANDA's Approved by Canada
      • Number of ANDA's Filed in Australia
      • Number of ANDA's Approved by Australia
      • Number of ANDA's Filed in South Africa
      • Number of ANDA's Approved by South Africa
      • Number of ANDA's Filed in Latam
      • Number of ANDA's Approved by Latam
      • Manufacturing Capacity - Piperazine (MTPA)
      • Manufacturing Capacity - Paracetamol (MTPA)
      • No of Pharmacy Outlets - Hyderabad (.)
      • No of Pharmacy Outlets - Bangalore (.)
      • No of Pharmacy Outlets - Chennai (.)
      Segments

      Select a Metric
      • Therapeutic wise Break-Up - Domestic Pharma (Crs)
      • Dermatology (Crs)
      • Cardiovascular (Crs)
      • Blood Related (Crs)
      • Antineo Plastic (Crs)
      • Anti-Malarial (Crs)
      • Anti - Infectives (Crs)
      • Vaccines (Crs)
      • Stomatological (Crs)
      • Sex Stimulants (Crs)
      • Respiratory (Crs)
      • Pain (Crs)
      • Others (Crs)
      • Ophthalmology (Crs)
      • Neurological (Crs)
      • Gynecology (Crs)
      • Gastro-Intestinal (Crs)
      • Endocrinology (Crs)
      • Urology (Crs)
      • Vitamin & Dietary Supplements (Crs)
      • Anti - Diabetes (Crs)
      • Indian vs MNC - Domestic Share (Crs)
      • Indian (Crs)
      • MNC (Crs)
      Export Import Data

      • 1y
      • 2y
      • 3y
      • 5y
      • 10y
        Select a Metric
        • Pharmaceutical Products (Kgs)
        Ideas Dashboard
        Results
        Timeline
        Watchlist
        Portfolio
        Alerts
        Stock Screener
        Market
        Raw Material